Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Schlichting

Showing results (71-80 of 106) with videos related to

Pageof 11
Sort By:
Movement Ecology|July 12, 2025
When, where, and how prey pair antipredator behaviors to natural and anthropogenic mortality risksMichael E Egan, Abigail M Weber, Nicole Gorman, et al.
Trials|October 10, 2021
Clinical effectiveness and safety of baricitinib for the treatment of juvenile idiopathic arthritis-associated uveitis or chronic anterior antinuclear antibody-positive uveitis: study protocol for an open-label, adalimumab active-controlled phase 3 clinical trial (JUVE-BRIGHT)Athimalaipet V Ramanan, Catherine M Guly, Stuart Y Keller, et al.
Journal of Burn Care & Research : Official Publication of the American Burn Association|May 4, 2019
Intoxication and Flame Burn Injuries in Young Adults in the United StatesMary A Palilonis, Siraj Amanullah, Annie Gjelsvik, et al.
The Journal of Pathology|November 26, 1998
Immunocytochemical detection of isolated epithelial cells in bone marrow: non-specific staining and contribution by plasma cells directly reactive to alkaline phosphataseE Borgen, K Beiske, S Trachsel, et al.
Pregnancy Hypertension|July 28, 2021
Association between maternal hypertensive disorders, fetal growth and childhood learning outcomesNina K Ayala, Lauren E Schlichting, Marga Kempner, et al.
The British Journal of Dermatology|January 23, 2016
A randomized phase 2b trial of baricitinib, an oral Janus kinase (JAK) 1/JAK2 inhibitor, in patients with moderate-to-severe psoriasisK A Papp, M A Menter, M Raman, et al.
Prion|July 11, 2025
Impact of low testing numbers on chronic wasting disease apparent prevalenceJameson J Mori, Nelda A Rivera, William M Brown, et al.
American Journal of Obstetrics & Gynecology MFM|December 21, 2020
Operative vaginal delivery and third grade educational outcomesNina K Ayala, Lauren E Schlichting, Martha B Kole, et al.
Rhode Island Medical Journal (2013)|May 29, 2024
Association Between Hispanic Ethnicity and Engagement in a Remote Postpartum Blood Pressure Monitoring Programs: Secondary Analysis of a Pilot Randomized TrialAdam K Lewkowitz, Lauren E Schlichting, Nina K Ayala, et al.
The Journal of Rheumatology|August 17, 2017
Safety and Efficacy of Baricitinib Through 128 Weeks in an Open-label, Longterm Extension Study in Patients with Rheumatoid ArthritisEdward C Keystone, Mark C Genovese, Douglas E Schlichting, et al.
Pageof 11

Showing results (71-80 of 106) with videos related to

Sort By:
Pageof 11
Movement Ecology|July 12, 2025
When, where, and how prey pair antipredator behaviors to natural and anthropogenic mortality risksMichael E Egan, Abigail M Weber, Nicole Gorman, et al.
Trials|October 10, 2021
Clinical effectiveness and safety of baricitinib for the treatment of juvenile idiopathic arthritis-associated uveitis or chronic anterior antinuclear antibody-positive uveitis: study protocol for an open-label, adalimumab active-controlled phase 3 clinical trial (JUVE-BRIGHT)Athimalaipet V Ramanan, Catherine M Guly, Stuart Y Keller, et al.
Journal of Burn Care & Research : Official Publication of the American Burn Association|May 4, 2019
Intoxication and Flame Burn Injuries in Young Adults in the United StatesMary A Palilonis, Siraj Amanullah, Annie Gjelsvik, et al.
The Journal of Pathology|November 26, 1998
Immunocytochemical detection of isolated epithelial cells in bone marrow: non-specific staining and contribution by plasma cells directly reactive to alkaline phosphataseE Borgen, K Beiske, S Trachsel, et al.
Pregnancy Hypertension|July 28, 2021
Association between maternal hypertensive disorders, fetal growth and childhood learning outcomesNina K Ayala, Lauren E Schlichting, Marga Kempner, et al.
The British Journal of Dermatology|January 23, 2016
A randomized phase 2b trial of baricitinib, an oral Janus kinase (JAK) 1/JAK2 inhibitor, in patients with moderate-to-severe psoriasisK A Papp, M A Menter, M Raman, et al.
Prion|July 11, 2025
Impact of low testing numbers on chronic wasting disease apparent prevalenceJameson J Mori, Nelda A Rivera, William M Brown, et al.
American Journal of Obstetrics & Gynecology MFM|December 21, 2020
Operative vaginal delivery and third grade educational outcomesNina K Ayala, Lauren E Schlichting, Martha B Kole, et al.
Rhode Island Medical Journal (2013)|May 29, 2024
Association Between Hispanic Ethnicity and Engagement in a Remote Postpartum Blood Pressure Monitoring Programs: Secondary Analysis of a Pilot Randomized TrialAdam K Lewkowitz, Lauren E Schlichting, Nina K Ayala, et al.
The Journal of Rheumatology|August 17, 2017
Safety and Efficacy of Baricitinib Through 128 Weeks in an Open-label, Longterm Extension Study in Patients with Rheumatoid ArthritisEdward C Keystone, Mark C Genovese, Douglas E Schlichting, et al.
Pageof 11